SCHEMBL18241586

SCHEMBL18241586

CC(=O)N[C@H]1[C@H](OC(C)=O)[C@@H]2OC[C@@H](O2)[C@@H]1OC(C)=O

nearest known ligand 0.34

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.34
▸ LMNA P02545 2/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ POLB P06746 2/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ ASGR1 P07306 2/20 0.31
▸ CA9 Q16790 4/20 0.30
▸ CA12 O43570 3/20 0.30
▸ CA1 P00915 3/20 0.30
▸ CA2 P00918 3/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10705909 0.82 KMT2A (0.37) KMT2ALMNAALDH1A1POLBL3MBTL1
SCHEMBL10526458 0.82 KMT2A (0.37) KMT2ALMNAALDH1A1POLBL3MBTL1
SCHEMBL2454869 0.80 CA9 (0.34) CA9CA12CA1CA2
SCHEMBL9050829 0.80 CA9 (0.34) CA9CA12CA1CA2
SCHEMBL7924602 0.80 CA9 (0.34) CA9CA12CA1CA2
SCHEMBL22729124 0.80 CA9 (0.34) CA9CA12CA1CA2
SCHEMBL12452164 0.77 KMT2A (0.37) KMT2AALDH1A1L3MBTL1ASGR1
SCHEMBL2835405 0.76 CA12 (0.31) CA9CA12CA1CA2
SCHEMBL2835403 0.76 CA12 (0.31) CA9CA12CA1CA2
SCHEMBL23969153 0.75 NEU3 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180180626-A1 A METHOD FOR DEVELOPMENT OF RECOMBINANT PROTEINS WITH FINGERPRINT LIKE SIMILARITY TO THE REFERENCE PRODUCT STC BIOLOGICS INC (US) 2018-06-28 — — US disclosed
US-9868973-B2 Method for optimizing post-translational modifications on recombinant proteins STC BIOLOGICS, INC. (US) 2018-01-16 — — US disclosed
US-20160340706-A1 Method for Optimizing Post-Translational Modifications on Recombinant Proteins STC BIOLOGICS, INC. 2016-11-24 — — US disclosed
Send feedback